| Disease specific survival | Time to relapse | ||||
Survival % n = 2005 | Univariate p value | Multivariate P value (HR [95% CI]) | Survival % n = 2005 | Univariate p value | Multivariate P value (HR [95% CI]) | |
Gender Female Male |
82.0 78.6 |
0.123 |
|
76.7 74.4 |
0.269 |
|
Age ≤70 >70 |
81.7 78.1 |
0.001 | 0.004 (1.5 [1.1 - 1.9]) |
70.6 80.3 |
<0.001 |
|
Diagnosis Adenocarcinoma Other cancer |
80.2 60.9 |
0.007 |
|
74.7 50.0 |
0.002 |
|
Metastasis at presentation No Yes |
75.8 56.7 |
<0.001 |
|
|
|
|
Neo adjuvant CT No Yes |
81.4 72.3 |
0.003 |
|
77.2 60.9 |
<0.001 |
|
Neo adjuvant RT No Yes |
81.1 75.8 |
0.119 |
|
76.9 63.5 |
<0.001 |
|
Adjuvant CT No Yes |
86.8 71.1 |
<0.001 |
|
83.0 66.4 |
<0.001 |
|
Adjuvant RT No Yes |
81.8 45.1 |
<0.001 |
|
76.2 62.5 |
0.009 |
|
Relapse No Yes |
91.6 43.0 |
<0.001 | <0.001 (12.6 [8.9 - 17.8]) |
- |
- |
|
T stage T1 T2 T3 T4 |
93.0 91.5 79.2 75.0 |
<0.001 |
|
87.5 88.1 77.4 58.9 |
<0.001 |
|
N stage N0 N1 N2 |
90.4 78.3 60.3 |
<0.001 |
|
83.7 72.9 58.0 |
<0.001 |
|
Dukes stage AR B C1 C2/D |
92.7 85.9 71.1 55.1 |
<0.001 |
0.019 (1.9 [1.1 - 3.5]) <0.001 (4.2 [2.5 - 7.3]) <0..01 (9.1 [5.0 - 16.8]) |
87.9 78.8 68.3 56.1 |
<0.001 |
0.047 (1.6 [1.0 - 2.6]) 0.009 (1.9 [1.2 - 3.2]) <0.001 (2.9 [1.6 - 5.2]) |
Treatment Surgery only Surgery + CT Surgery + RT Surgery + RT + CT |
88.3 73.4 63.6 71.6 |
<0.001 |
|
|
|
|